|
⚲
|
| Keyboard |
| Roberts John A
✚
|
|
|---|---|
| CIK # | 0001249872 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001249872] | |
| 4 | [0001249872] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Roberts John A | |
| Cingulate Inc | |
| Cancer Genetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cingulate Inc CING
Stock Option (right to Buy) · derivative
|
2025-06-20 | Grant | 15,000 | $0.00 | |
|
Cingulate Inc CING
Stock Option (right to Buy) · derivative
|
2024-06-12 | Grant | 10,000 | $0.00 | |
|
Cingulate Inc CING
Stock Option (right to Buy) · derivative
|
2024-06-11 | Grant | 14,750 | ||
|
Cingulate Inc CING
Stock Option (right to Buy) · derivative
|
2024-06-11 | Grant | 5,000 | $0.00 | |
|
Cingulate Inc CING
Stock Option (right to Buy) · derivative
|
2024-03-04 | Grant | 5,000 | $0.00 | |
|
Cancer Genetics Inc VYNT
Stock option (right to buy) · derivative
|
2022-03-15 | Grant | 150,000 | $0.00 | |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-11-24 | Buy | 5,000 | $2.02 | 10,100 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-08-23 | Buy | 10,406 | $2.41 | 25,078 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-05-26 | Buy | 7,041 | $3.55 | 24,996 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-05-24 | Buy | 7,440 | $3.38 | 25,147 |
|
Cancer Genetics Inc VYNT
Stock option (right to buy) · derivative
|
2021-03-30 | Grant | 250,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2019-01-31 | Buy | 185,436 | $0.23 | 42,650 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2019-01-14 | Buy | 100,000 | $0.23 | 23,000 |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2018-05-10 | Grant | 350,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock
|
2017-12-15 | Buy | 12,200 | $2.00 | 24,400 |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-02-22 | Grant | 30,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2016-07-11 | Grant | 120,000 | $0.00 |